FDA inspection
Aurolife Pharma, LLC: FDA inspection ending Oct 23, 2019
FDA inspection 1109887 · Voluntary Action Indicated (VAI) · East Windsor, NJ
Key facts
| Inspection ID | 1109887 |
|---|---|
| Firm | Aurolife Pharma, LLC |
| FEI number | 3014026025 |
| Address | 203 Windsor Center, Suite Iii |
| City | East Windsor |
| State | NJ |
| ZIP | 8520 |
| Fiscal year | 2020 |
| Inspection end date | Oct 23, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data